ReviewFrontiers in immunology2022
The NLRP3 inflammasome as a new target in respiratory disorders treatment.
Katarzyna Leszczyńska et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
34 papers cite it
this papercites it
ReviewFrontiers in immunology2022
Katarzyna Leszczyńska et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.